Radicava Sales Uptake Key to Maintaining Flat Top-Line Over the Next 3-5 Years
We reiterate our “Equal-weight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earningsDomestic pharma, contributing >70%...
1k Views
𝛼SK or SearchENTITY
Akebia Therapeutics (AKBA US)
Akebia Therapeutics (AKBA US)
6
Analysis
Health Care • United States
Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.
morex